# BIORELIX INC: Form D filings

BIORELIX INC, a pharmaceuticals company in New Haven, CT, filed 5 Form D notices with the SEC between 2009 and 2012. The latest, on March 13, 2012, reports $2.6 million sold of a $2.6 million offering to 8 investors.

Find out what BIORELIX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20BIORELIX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=BIORELIX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fbiorelix-inc-1373982)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20BIORELIX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=BIORELIX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fbiorelix-inc-1373982)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5 SCIENCE PARK, 401 WINCHESTER AVENUE, New Haven, CT, 06511
- Phone: (203) 785-9282
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1373982

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 13, 2012 | New notice | $2,558,096 | $2,558,096 | $0 | 8 | Mar 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1373982/000137398212000001/0001373982-12-000001-index.htm) |
| Sep 2, 2011 | New notice | $5,310,886 | $3,644,085 | $1,666,801 | 8 | Aug 24, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1373982/000139460611000004/0001394606-11-000004-index.htm) |
| Dec 22, 2010 | New notice | $4,800,000 | $2,400,000 | $2,400,000 | 7 | Dec 14, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1373982/000137398210000003/0001373982-10-000003-index.htm) |
| Jan 27, 2010 | Amendment | $7,492,835 | $5,535,199 | $1,957,636 | 7 | Jul 9, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1373982/000137398210000002/0001373982-10-000002-index.htm) |
| Jul 15, 2009 | New notice | $3,579,005 | $1,789,505 | $1,789,500 | 7 | Jul 9, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1373982/000137398209000004/0001373982-09-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Philippe R. Chambon | Director |  |
| Brian R. Dixon, Ph.D | Executive Officer, Director |  |
| A. Donny Strosberg | Director |  |
| Ronald R. Lennox | Executive Officer, Director |  |
| William R. Wiesler | Director |  |
| Campbell Donny Murray | Director |  |

## Other pharmaceuticals companies in Connecticut that filed recently

- [Thetis Pharmaceuticals LLC](https://specstream.ai/data/form-d/company/thetis-pharmaceuticals-llc-1528491) $560,300 · Oct 13, 2026
- [Inventure, LLC](https://specstream.ai/data/form-d/company/inventure-llc-1706556) $82,345 · Sep 3, 2026

[Every Form D from the week of Mar 12, 2012](https://specstream.ai/data/form-d/week/2012-03-12) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what BIORELIX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).